Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Nanomedicine Market to reach US$ 512.47 billion by 2028, Says TMR

This image opens in the lightbox

News provided by

Transparency Market Research

04 Mar, 2022, 11:30 GMT

Share this article

Share toX

Share this article

Share toX

- Efficacy of nanomedicine for targeted drug delivery at the right rate of delivery in the right proportion to boost nanomedicine market

- Extensive use of nanomedicine in the treatment of chronic diseases to enable rapid metabolism of medications in the body to stimulate adoption

ALBANY, N.Y., March 4, 2022 /PRNewswire/ -- The nanomedicine market is estimated to expand at a CAGR of 12.6% for the forecast period from 2021 to 2028. Consistent R&D in nanomedicine with the need to identify and exploit the full potential of current technologies for nanomedicine such as nanoparticles, nanocarriers, and nanosensors is anticipated to create monumental opportunities in nanomedicine market.

Nanomedicine is used extensively in the treatment of chronic diseases such as diabetes, cardiovascular diseases, and dementia wherein it enables the rapid metabolism of medication in the body. Nanomedicine technologies such as nanoparticle based diagnostic agents, targeted drug delivery, and conjugated drug nanoparticles currently find an array of medical applications.

Prospects of development of new technologies such as molecular nanotechnology, nanorobots, and nanovaccinology to open up new application areas of nanomedicine will stimulate the growth of nanomedicine market. For instance, lab-on-chip technology is looked upon to benefit healthcare diagnostics due to increased accuracy with reduced sample size.

Request Brochure of Nanomedicine Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1753

Nanomedicine Market – Key Findings of Report

  • Efficacy of nanomedicine to deliver drugs at the target site at the right rate of delivery in the right proportion for complicated disease conditions such as cancer spurs adoption
  • Advances in nanomedicine attempts to fill the wide gap between patient needs and available line of treatment beyond breakthrough medical therapies such as portable imaging and advanced medical sensors
  • Prospects of expanding potential of nantechnology in in vivo imaging, such as improving contrast and distribution in ultrasound and MRI that points at improved diagnostics and identified medication distribution & metabolism in the body to contribute to growth of nanomedicine market

Request for Analysis of COVID-19 Impact on Nanomedicine Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1753

  • Array of nanomedicine technologies such as targeted drug delivery, conjugated drug particles, and nanoparticle based diagnostic agents witness medical applications
  • Challenges of low concentration of nanomedicine technology and small number of nanomaterial suppliers account for hospitals to mostly make long-term contracts with suppliers with pre-negotiated terms and conditions for uninterrupted supply of raw materials
  • Demand for array of nanomedical products such as nanorobots, monoclonal antibody-based immunoassays, DNA probes, nanosensors, and nanoparticle-based imaging agents stirs with increasing healthcare spending and improving healthcare facilities in developing countries
  • Oncology segment held the leading share in nanomedicine market in 2020. Applications of nanotechnology in cancer diagnosis and treatment have yielded promising results for drug delivery, drug carriage, gene therapy, targeted therapy, molecular imaging, and biomarker mapping.
  • Adoption of nanomedicine to treat cancer is also related to improved responsiveness against tumors by acting as carriers of drug, and as an adjuvant for vaccine therapy to help target tumors more effectively
  • North America is a key region in the nanomedicine market. Presence of avant-garde healthcare infrastructure facilitates the advancements of nanomedical products such as DNA probes, nanorobots, nanosensors, monoclonal antibody-based immunoassays, and nanoparticle-based imaging agents in healthcare facilities of the region.

Make an Enquiry before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=1753

Nanomedicine Market – Growth Drivers

  • Several medical applications of nanomedicine in the diagnosis, treatment, monitoring, and control of biological systems for improved medicine drug delivery, which involves manipulating materials on nanoscale fuel the growth of nanomedicine market
  • Advancement in drug delivery technologies along with rise in acceptance of nanomedicine for various medical applications stimulates nanomedicine market

Nanomedicine Market – Key Players

Some of the key players operating in the nanomedicine market are;

  • GE Healthcare
  • Abbott Laboratories
  • Nanosphere Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Celgene Corporation
  • Life Technologies
  • Gilead Sciences Inc.
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Mallinckrodt plc
  • Sigma-Tau Pharmaceuticals Inc.
  • Novavax Inc.
  • MagArray Inc.

The nanomedicine market is segmented as follows;

Global Nanomedicine Market, by Application

  • Neurology
  • Cardiovascular
  • Anti-inflammatory
  • Anti-infectives
  • Oncology
  • Others

Global Nanomedicine Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Cardiovascular Drugs Market: The demand within the global cardiovascular drugs market is expected to rise in the years to follow. The aforementioned projection is based on the rising incidence of heart diseases, strokes, and cardiac arrests. The field of cardiology has become the cynosure of the healthcare industry, and regional governments have made heavy investments in this sector.

Biological Optical Microscope Market: Market players in the ASEAN biological optical microscope market are focusing on increasing their efforts to manufacture highly efficient microscopes. Growing research & development activities in the microbiology and study of cell structure & other biological specimen are driving the demand for optical microscopes.

Topical Drug Delivery Systems Market: The growing incidence and prevalence rate of tropical diseases is boosting the growth of the topical drug delivery systems market. North America dominates the global market for topical drug delivery systems owing to high incidence of skin diseases, growing awareness about cosmetic care, high health care expenditure, and growing R&D activities in the transdermal drug delivery systems by players located in the U.S.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Access MarketNgage: The On Demand, Subscription based platform from Transparency Market Research

www.marketngage.com 

Now avail flexible Market Research Subscription through MarketNgage, the Market Research Subscription Platform from Transparency Market Research and other iconic market research powerhouses. Go beyond just reports and access research multi-format through downloadable executive summaries, chapters, databooks, infographics, charts, interactive playbook for data visualization and full reports across all major industries, 200+ sub sectors and 1200+ niche markets, through MarketNgage.

Sign Up for a 7 day free trial!

Contact

Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/nanomedicine-market.htm

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg

Modal title

Also from this source

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Ultra-high Purity Anhydrous Hydrogen Chloride (HCl) Gas Market to Reach USD 5.7 Billion by 2031, Expanding at a CAGR of 5.4% | TMR Report

Over the last year, several companies have announced new semiconductor fabrication sites, especially in the U.S., India, and Europe. These...

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

Silicon Metal Market Size Projected to Expand to USD 10.7 Billion by 2031 Exhibiting 5.1% CAGR: Transparency Market Research, Inc.

The market was valued at US$ 6.9 billion in 2022. The Silicon Metal Market Growth is estimated to reach US$ 10.7 billion by the end of 2031,...

More Releases From This Source

Explore

Nanotechnology

Nanotechnology

Computer & Electronics

Computer & Electronics

Pharmaceuticals

Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.